SlideShare a Scribd company logo
need-to-know
facts from ISR’s
1. CROs with both in-life and
bioanalytical capabilites are #1.
Almost half of respondents prefer that CROs with
both in-life and bioanalytical capabilities perform
their preclinical bioanalytical lab work. However,
nearly 40% prefer specialized providers.
In-life and
bioanalytical
CROs (e.g.
Quintiles, PPD,
Covance), 48%
Specialized
bioanalytical
providers (e.g.
BioAgilytix,
Ricerca, BASi),
39%
Using in-house
resources, 13%
© Industry Standard Research
2. Respondents expect technical
expertise in their providers.
Respondents rating technical attributes important
for immunochemistry provider selection identified
technical expertise as the most important attribute.
See ISR’s full report for mass spectrometry figures.
© Industry Standard Research
57%
27%
0% 10% 20% 30% 40% 50% 60%
Broad non-proprietary
assay list
Analytical resources
Broad biomarker assay
list
Assay development
expertise
Method development
turnaround time
On-time delivery of
sample analysis data
files
Biomarker capabilities
Technical expertise
% of Respondents
Most important
Top 3
D A T A I N F U L L R E P O R T
3. Labs are rated on capability,
delivery, and pricing metrics.
Respondents rated bioanalytical labs’ performances
relative to the respondent’s expectations. ISR found
many companies listed as top performers were
ranked lower in initial perception. ©IndustryStandardResearch
C O M P A N I E S H A V E B E E N R A N D O M I Z E D
Analytical resources
Flexibility
in
reporting
Assay
developm
ent expertise
G
eographic
coverage
Low
cost
C
om
m
unication
Biom
arker capabilities
Innovative
pricing
m
odels
O
n-tim
e
delivery
M
ethod
developm
ent turnaround
tim
e
Technical expertise
0.37 0.19 0.09 0.30 0.10 -0.05 0.34 0.21 0.29 0.41 0.21
0.18 0.06 0.18 0.30 -0.11 -0.11 -0.30 0.24 0.12 0.12 0.12
0.08 0.17 -0.33 -0.41 -0.41 -0.07 -0.09 0.09 0.00 0.25 0.40
0.49 0.33 0.24 0.41 0.33 0.09 0.09 0.25 0.49 0.49 0.24
0.08 0.00 -0.04 -0.09 0.04 -0.06 -0.18 0.01 0.02 0.18 0.18
0.35 0.55 0.35 0.35 0.10 0.10 -0.05 0.35 0.00 0.15 0.65
0.12 0.12 0.08 0.04 0.38 -0.14 -0.27 -0.03 0.09 -0.10 0.13
0.18 0.28 0.04 0.21 0.19 -0.31 -0.40 -0.04 -0.07 0.09 0.31
COMPANY A
COMPANY B
COMPANY C
COMPANY D
COMPANY E
COMPANY F
COMPANY G
COMPANY H
4. Using a single bioanalytical
lab is interesting, but risky.
While the majority of respondents acknowledge
that a single service provider could meet most of
their needs, respondents also expressed
apprehension for only using one.
64%
72% agree that ‘one bioanalytical lab service provider could meet
the majority of our company’s needs.’
agree that ‘using one bioanalytical lab for the majority of our
company’s needs is too risky.’
© Industry Standard Research
5. There are distinct
tiers of high performers.
ISR observed three distinct tiers occupying the first
ten spots throughout respondents’ rankings for
familiarity, perceived leadership (above), expected
proposal volume, and usage.
14%
14%
15%
16%
18%
20%
31%
33%
37%
50%
0% 10% 20% 30% 40% 50% 60%
Tier 3
Tier 3
Tier 3
Tier 3
Tier 3
Tier 3
Tier 2
Tier 2
Tier 2
Tier 1
% of Respondents
© Industry Standard Research
BIOANALYTICAL
LABS MARKET
DYNAMICS AND
SERVICE PROVIDER
PERFORMANCE
(3RD EDITION)
J U N E , 2 0 1 7
P R E V I E W O F
GET THE FULL PICTURE
Need more info on
the bioanalytical lab
market? Purchase the
full report at
ISRreports.com.
Contact us at
info@ISRreports.com
or (919) 301-0106

More Related Content

PDF
SCIO – Explore Me, IoT Israel 2014
PDF
Molecular Sensor from SCIO
PDF
BOORSTEIN.tue_.4pm.Final_
PDF
Medergo
DOCX
Medical Device Biocompatibility
PDF
WHY THE LABORATORIES NEED QUALITY CONTROL AND STANDARDIZATION
PDF
Antibody Drug Conjugates - Survey
PPTX
Magnamosis inc final presentation 12 10
SCIO – Explore Me, IoT Israel 2014
Molecular Sensor from SCIO
BOORSTEIN.tue_.4pm.Final_
Medergo
Medical Device Biocompatibility
WHY THE LABORATORIES NEED QUALITY CONTROL AND STANDARDIZATION
Antibody Drug Conjugates - Survey
Magnamosis inc final presentation 12 10

What's hot (9)

PDF
Rating & uprating handbook
PDF
Medical journal app for physicians and researchers
PPTX
Result care lean launchpad week 1 slides v2
PPTX
PAYING FOR BREAKTHROUGH EYE THERAPIES (BIOLOGICS, BIOSIMILARS & GENE THERAPIES)
PPTX
PAYING FOR BREAKTHROUGH EYE THERAPIES (BIOLOGICS, BIOSIMILARS & GENE THERAPIE...
PPTX
Pistoia Alliance conference April 2016: Mini Startup Challenge: Agewell
PPTX
Holobiome final presentation 7
PDF
2012ComputerizedMixInjectionWorkshop
Rating & uprating handbook
Medical journal app for physicians and researchers
Result care lean launchpad week 1 slides v2
PAYING FOR BREAKTHROUGH EYE THERAPIES (BIOLOGICS, BIOSIMILARS & GENE THERAPIES)
PAYING FOR BREAKTHROUGH EYE THERAPIES (BIOLOGICS, BIOSIMILARS & GENE THERAPIE...
Pistoia Alliance conference April 2016: Mini Startup Challenge: Agewell
Holobiome final presentation 7
2012ComputerizedMixInjectionWorkshop
Ad

Similar to Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edition) (13)

PDF
Clinical Laboratory Services Market a Surge in Demand for High-Quality Testing
PDF
Recommendations on biomarker bioanalytical method validation by GCC (Global C...
PDF
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...
PDF
PSL Company Brochure
PDF
Quality for Biologics
PDF
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
PDF
The 2012 European Clinical Chemistry and Immunodiagnostics Markets:<br>Fra...
PDF
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...
PDF
Outsourcing: challenges and successes
PDF
Innovative PSA Testing Technologies and Emerging Markets
PDF
2013 Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities a...
PDF
Global Regulatory Issues: one BA method, one validation, one report ...
PDF
Future Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities...
Clinical Laboratory Services Market a Surge in Demand for High-Quality Testing
Recommendations on biomarker bioanalytical method validation by GCC (Global C...
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...
PSL Company Brochure
Quality for Biologics
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
The 2012 European Clinical Chemistry and Immunodiagnostics Markets:<br>Fra...
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...
Outsourcing: challenges and successes
Innovative PSA Testing Technologies and Emerging Markets
2013 Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities a...
Global Regulatory Issues: one BA method, one validation, one report ...
Future Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities...
Ad

More from Industry Standard Research (20)

PDF
Electronic Media Use in Academic Medical Center Patient Recruitment
PDF
Personalized Medicine's Effect on Oncologists' Treatment Regimens
PDF
Regulatory Affairs: Department Models and Structures
PDF
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
PDF
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
PDF
Market Access: department models and structures
PDF
Infographic: The World of Drug Development Trends
PDF
Infographic: eClinical Trends, Tips, and Technology
PDF
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
PDF
PDF
Infographic: Ovarian Cancer Profile
PDF
Infographic: CRO Capital Market
PDF
2014 Clinical Development Year in Review
PDF
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
PDF
Benchmarking the Pharma Industry’s Medical Affairs Functions
PDF
Bladder Cancer: profile and drug development
PDF
Clinical development activity in perspective: A head-to-head comparison of ...
PDF
[Infographic] Lung Cancer
PDF
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
PDF
Clinical Development Year in Review (2013)
Electronic Media Use in Academic Medical Center Patient Recruitment
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Regulatory Affairs: Department Models and Structures
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Market Access: department models and structures
Infographic: The World of Drug Development Trends
Infographic: eClinical Trends, Tips, and Technology
EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)
Infographic: Ovarian Cancer Profile
Infographic: CRO Capital Market
2014 Clinical Development Year in Review
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Benchmarking the Pharma Industry’s Medical Affairs Functions
Bladder Cancer: profile and drug development
Clinical development activity in perspective: A head-to-head comparison of ...
[Infographic] Lung Cancer
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Clinical Development Year in Review (2013)

Recently uploaded (20)

PDF
BF and FI - Blockchain, fintech and Financial Innovation Lesson 2.pdf
PDF
.pdf is not working space design for the following data for the following dat...
PPTX
Introduction to Knowledge Engineering Part 1
PPTX
IBA_Chapter_11_Slides_Final_Accessible.pptx
PPTX
ALIMENTARY AND BILIARY CONDITIONS 3-1.pptx
PPTX
MODULE 8 - DISASTER risk PREPAREDNESS.pptx
PPTX
advance b rammar.pptxfdgdfgdfsgdfgsdgfdfgdfgsdfgdfgdfg
PPTX
Moving the Public Sector (Government) to a Digital Adoption
PPTX
climate analysis of Dhaka ,Banglades.pptx
PDF
Introduction to Business Data Analytics.
PPTX
Business Ppt On Nestle.pptx huunnnhhgfvu
PPTX
Introduction-to-Cloud-ComputingFinal.pptx
PPTX
IB Computer Science - Internal Assessment.pptx
PPTX
Global journeys: estimating international migration
PDF
Clinical guidelines as a resource for EBP(1).pdf
PPTX
mbdjdhjjodule 5-1 rhfhhfjtjjhafbrhfnfbbfnb
PDF
TRAFFIC-MANAGEMENT-AND-ACCIDENT-INVESTIGATION-WITH-DRIVING-PDF-FILE.pdf
PDF
22.Patil - Early prediction of Alzheimer’s disease using convolutional neural...
PPT
Reliability_Chapter_ presentation 1221.5784
PPT
Miokarditis (Inflamasi pada Otot Jantung)
BF and FI - Blockchain, fintech and Financial Innovation Lesson 2.pdf
.pdf is not working space design for the following data for the following dat...
Introduction to Knowledge Engineering Part 1
IBA_Chapter_11_Slides_Final_Accessible.pptx
ALIMENTARY AND BILIARY CONDITIONS 3-1.pptx
MODULE 8 - DISASTER risk PREPAREDNESS.pptx
advance b rammar.pptxfdgdfgdfsgdfgsdgfdfgdfgsdfgdfgdfg
Moving the Public Sector (Government) to a Digital Adoption
climate analysis of Dhaka ,Banglades.pptx
Introduction to Business Data Analytics.
Business Ppt On Nestle.pptx huunnnhhgfvu
Introduction-to-Cloud-ComputingFinal.pptx
IB Computer Science - Internal Assessment.pptx
Global journeys: estimating international migration
Clinical guidelines as a resource for EBP(1).pdf
mbdjdhjjodule 5-1 rhfhhfjtjjhafbrhfnfbbfnb
TRAFFIC-MANAGEMENT-AND-ACCIDENT-INVESTIGATION-WITH-DRIVING-PDF-FILE.pdf
22.Patil - Early prediction of Alzheimer’s disease using convolutional neural...
Reliability_Chapter_ presentation 1221.5784
Miokarditis (Inflamasi pada Otot Jantung)

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edition)

  • 2. 1. CROs with both in-life and bioanalytical capabilites are #1. Almost half of respondents prefer that CROs with both in-life and bioanalytical capabilities perform their preclinical bioanalytical lab work. However, nearly 40% prefer specialized providers. In-life and bioanalytical CROs (e.g. Quintiles, PPD, Covance), 48% Specialized bioanalytical providers (e.g. BioAgilytix, Ricerca, BASi), 39% Using in-house resources, 13% © Industry Standard Research
  • 3. 2. Respondents expect technical expertise in their providers. Respondents rating technical attributes important for immunochemistry provider selection identified technical expertise as the most important attribute. See ISR’s full report for mass spectrometry figures. © Industry Standard Research 57% 27% 0% 10% 20% 30% 40% 50% 60% Broad non-proprietary assay list Analytical resources Broad biomarker assay list Assay development expertise Method development turnaround time On-time delivery of sample analysis data files Biomarker capabilities Technical expertise % of Respondents Most important Top 3 D A T A I N F U L L R E P O R T
  • 4. 3. Labs are rated on capability, delivery, and pricing metrics. Respondents rated bioanalytical labs’ performances relative to the respondent’s expectations. ISR found many companies listed as top performers were ranked lower in initial perception. ©IndustryStandardResearch C O M P A N I E S H A V E B E E N R A N D O M I Z E D Analytical resources Flexibility in reporting Assay developm ent expertise G eographic coverage Low cost C om m unication Biom arker capabilities Innovative pricing m odels O n-tim e delivery M ethod developm ent turnaround tim e Technical expertise 0.37 0.19 0.09 0.30 0.10 -0.05 0.34 0.21 0.29 0.41 0.21 0.18 0.06 0.18 0.30 -0.11 -0.11 -0.30 0.24 0.12 0.12 0.12 0.08 0.17 -0.33 -0.41 -0.41 -0.07 -0.09 0.09 0.00 0.25 0.40 0.49 0.33 0.24 0.41 0.33 0.09 0.09 0.25 0.49 0.49 0.24 0.08 0.00 -0.04 -0.09 0.04 -0.06 -0.18 0.01 0.02 0.18 0.18 0.35 0.55 0.35 0.35 0.10 0.10 -0.05 0.35 0.00 0.15 0.65 0.12 0.12 0.08 0.04 0.38 -0.14 -0.27 -0.03 0.09 -0.10 0.13 0.18 0.28 0.04 0.21 0.19 -0.31 -0.40 -0.04 -0.07 0.09 0.31 COMPANY A COMPANY B COMPANY C COMPANY D COMPANY E COMPANY F COMPANY G COMPANY H
  • 5. 4. Using a single bioanalytical lab is interesting, but risky. While the majority of respondents acknowledge that a single service provider could meet most of their needs, respondents also expressed apprehension for only using one. 64% 72% agree that ‘one bioanalytical lab service provider could meet the majority of our company’s needs.’ agree that ‘using one bioanalytical lab for the majority of our company’s needs is too risky.’ © Industry Standard Research
  • 6. 5. There are distinct tiers of high performers. ISR observed three distinct tiers occupying the first ten spots throughout respondents’ rankings for familiarity, perceived leadership (above), expected proposal volume, and usage. 14% 14% 15% 16% 18% 20% 31% 33% 37% 50% 0% 10% 20% 30% 40% 50% 60% Tier 3 Tier 3 Tier 3 Tier 3 Tier 3 Tier 3 Tier 2 Tier 2 Tier 2 Tier 1 % of Respondents © Industry Standard Research
  • 7. BIOANALYTICAL LABS MARKET DYNAMICS AND SERVICE PROVIDER PERFORMANCE (3RD EDITION) J U N E , 2 0 1 7 P R E V I E W O F GET THE FULL PICTURE Need more info on the bioanalytical lab market? Purchase the full report at ISRreports.com. Contact us at info@ISRreports.com or (919) 301-0106